Laragh J H
Drugs. 1986;32 Suppl 5:1-12. doi: 10.2165/00003495-198600325-00002.
Overactivity of the renin-angiotensin-aldosterone system occurs in the syndrome of congestive cardiac failure. Aldosterone overactivity is crucially involved in maintaining the oedematous state as evidenced by its often complete correction by adrenalectomy, or by aldosterone antagonists, in both experimental and clinical heart failure. The hyperaldosteronism of heart failure can also be attacked by angiotensin-converting enzyme (ACE) inhibition, which not only blocks the angiotensin drive to aldosterone, but also unloads the heart by blocking renin-angiotensin-mediated vasoconstriction. Accordingly, ACE inhibition alone, if continued in full dosage, can often reduce or obviate the need for daily thiazide diuretic therapy. This specific, two-pronged therapy with fewer side effects emerges as a primary strategy for the treatment of congestive heart failure. To learn more about why and how the renin system becomes involved in heart failure, the renal functional abnormalities have been re-examined. The effects of sodium administration on central haemodynamics and on the activity of the renin system have als been studied. This research has led to a consideration of the role of atrial natriuretic hormone in this pathophysiological interplay. The study recharacterized renal haemodynamic patterns and indicated that in congestive heart failure there is a disproportionate diversion of blood away from the kidneys because of afferent vasoconstriction. However, the glomerular filtration rate is maintained by concurrent efferent arteriolar constriction, expressed by a rising filtration fraction. As heart failure advances, the filtration fraction can no longer rise. At this point, the glomerular filtration rate becomes flow-dependent and falls commensurately with the declining cardiac output. These intrarenal patterns may be mediated in part by increased intrarenal renin activity resulting from heart failure and diuretic therapy. A further study of the abnormal renin system activity operating in heart failure has shown it to be very sensitive to dietary salt intake. Thus, consuming modest amounts of salt (100 mEq/day) was sufficient to markedly suppress renin and aldosterone values. However, since peripheral resistance was not changed, another non-renin, sodium-related mechanism must take over to sustain increased arterial constriction. The fact that captopril challenge evoked no response before and a large response after sodium depletion supports this concept. preliminary data suggest that atrial natriuretic hormone may also be important in congestive heart failure by opposing renin system activity at 4 sites.(ABSTRACT TRUNCATED AT 400 WORDS)
肾素 - 血管紧张素 - 醛固酮系统活性亢进见于充血性心力衰竭综合征。醛固酮活性亢进在维持水肿状态中起关键作用,实验性和临床心力衰竭中,肾上腺切除术或使用醛固酮拮抗剂常常能完全纠正水肿,证明了这一点。心力衰竭时的醛固酮增多症也可通过抑制血管紧张素转换酶(ACE)来治疗,这不仅能阻断血管紧张素对醛固酮的作用,还能通过阻断肾素 - 血管紧张素介导的血管收缩来减轻心脏负担。因此,仅持续足量使用ACE抑制剂,常常可减少或无需每日使用噻嗪类利尿剂治疗。这种副作用较少的特异性双管齐下治疗方法,成为治疗充血性心力衰竭的主要策略。为了更多地了解肾素系统为何以及如何参与心力衰竭,对肾功能异常进行了重新审视。还研究了给予钠对中心血流动力学和肾素系统活性的影响。这项研究促使人们考虑心房利钠肽在这种病理生理相互作用中的作用。该研究重新描述了肾血流动力学模式,并表明在充血性心力衰竭中,由于入球小动脉收缩,血液不成比例地从肾脏分流。然而,肾小球滤过率通过出球小动脉同时收缩得以维持,表现为滤过分数升高。随着心力衰竭进展,滤过分数不再升高。此时,肾小球滤过率变得依赖于血流量,并随心脏输出量下降而相应降低。这些肾内模式可能部分由心力衰竭和利尿剂治疗导致的肾内肾素活性增加介导。对心力衰竭中异常肾素系统活性的进一步研究表明,它对饮食中盐的摄入量非常敏感。因此,摄入适量盐(100 mEq/天)足以显著抑制肾素和醛固酮值。然而,由于外周阻力未改变,必须有另一种与肾素无关的、与钠相关的机制来维持动脉收缩增强。卡托普利激发试验在钠缺乏前无反应而在钠缺乏后有大反应这一事实支持了这一概念。初步数据表明,心房利钠肽在充血性心力衰竭中也可能很重要,因为它在4个部位对抗肾素系统活性。(摘要截选至400字)